Patents by Inventor J. Michael Conlon

J. Michael Conlon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Esculentin-2CHa peptide and analogues thereof
    Patent number: 10202427
    Abstract: The present invention relates to an esculentin-2CHa peptide and analogs thereof, and the use each thereof in the treatment of diabetes, for example type 2 diabetes; insulin resistance; obesity, and/or hypercholesterolemia. Also disclosed is a pharmaceutical composition comprising peptides and analogs according to the present invention; use of peptides and analogs according to the present invention for the manufacture of a medicament for the treatment of diabetes, insulin resistance, obesity, and/or hypercholesterolemia; and methods of treating diabetes, insulin resistance, obesity, and/or hypercholesterolemia.
    Type: Grant
    Filed: February 2, 2015
    Date of Patent: February 12, 2019
    Assignee: UNIVERSITY OF ULSTER
    Inventors: Yasser Abdel-Wahab, Peter Flatt, Opeolu Ojo, J. Michael Conlon
  • Anti-tumor effects of GnRH-III
    Patent number: 5593965
    Abstract: The present invention provides a novel pharmaceutical composition for the treatment of breast cancer. Also provided are various methods of treating breast cancer.
    Type: Grant
    Filed: October 20, 1994
    Date of Patent: January 14, 1997
    Assignee: Creighton University
    Inventors: Sandor Lovas, J. Michael Conlon, Borbala Vincze, Istvan Palyi, Dezso Gaal, Adrienn Kalnay, Imre Mezo, Istvan Teplan, Geza Toth, Magdolna Kovacs
  • Neuropeptides of the tachykinin family
    Patent number: 5304632
    Abstract: The invention relates to a peptide, characterized in that it corresponds to the following sequence of amino acids:Xaa.sub.1 Pro Xaa.sub.2 Pro Xaa.sub.3 Xaa.sub.4 Phe Tyr Gly Leu Metin which a.sub.n with n equal to 1, 2, 3 or 4 represents any amino acid, and in particular in that the peptide is ranakinin having the following formula:Lys Pro Asn Pro Glu Arg Phe Tyr Gly Leu MetThe invention also relates to the use of this peptide in pharmacological applications.
    Type: Grant
    Filed: September 3, 1991
    Date of Patent: April 19, 1994
    Assignees: Creighton University, Centre National de la Recherche Scientifique
    Inventors: Hubert Vaudry, J. Michael Conlon